The net consolidated gain of Pharma Major Dr. Reddy Labiatories LTD increased by 21 percent in the fourth quarter that ended on March 31, 2025 to ₹ 1,587 million rupees against ₹ 1,307 million rupees in the corresponding period of the previous financial year.
Hyderab -headquarters’ total revenues increased 20 percent to ₹ 8,506 million rupees in the period under review compared to ₹ 7,083 million rupees in the previous year.
When commenting on the results, Cohairman & MD, GV Prasad, said: “We achieved a two -digit growth in our businesses, driven by successful product releases, higher income of key products in the United States and the acquired NRT.” “
Dr. Reddy will continue to strengthen and increase its main businesses through the management of the portfolio and operational excellence, while seeking strategic associations and inorganic growth opportunities, he added.
Throughout the year of the 2015 fiscal year, it registered a 2 percent increase in net gain to ₹ 5,655 million rupees in a growth of 17 percent in revenues to ₹ 3,255.4 million rupees.
Posted on May 9, 2025
